117 related articles for article (PubMed ID: 3289800)
1. The immune response to the cell wall of Mycobacterium bovis BCG.
Orme IM
Clin Exp Immunol; 1988 Mar; 71(3):388-93. PubMed ID: 3289800
[TBL] [Abstract][Full Text] [Related]
2. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
3. Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice.
Brandely M; Lagrange PH; Hurtrel B
Clin Exp Immunol; 1986 Jan; 63(1):118-26. PubMed ID: 3514011
[TBL] [Abstract][Full Text] [Related]
4. Acquired immunity to heavy infection with Mycobacterium bovis bacillus Calmette-Guérin and its relationship to the development of nonspecific unresponsiveness in vitro.
Orme IM; Ratcliffe MJ; Collins FM
Cell Immunol; 1984 Oct; 88(2):285-96. PubMed ID: 6386183
[TBL] [Abstract][Full Text] [Related]
5. Evolution of cell types and T-cell subsets in the spleens of Mycobacterium bovis BCG-resistant and M. bovis BCG-susceptible strains of mice after infection with M. bovis BCG.
Denis M; Forget A; Miailhe AC; Pelletier M; Skamene E
Infect Immun; 1985 Jul; 49(1):253-5. PubMed ID: 3891628
[TBL] [Abstract][Full Text] [Related]
6. Strain difference in delayed-type hypersensitivity to BCG in mice: role of splenic adherent cells in the primary immune response.
Nakamura RM; Tanaka H; Tokunaga T
Immunology; 1982 Dec; 47(4):729-31. PubMed ID: 6216204
[No Abstract] [Full Text] [Related]
7. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin.
Orme IM; Collins FM
Cell Immunol; 1984 Mar; 84(1):113-20. PubMed ID: 6421492
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.
Bourassa D; Forget A; Pelletier M; Skamene E; Turcotte R
Clin Exp Immunol; 1985 Oct; 62(1):31-8. PubMed ID: 3905097
[TBL] [Abstract][Full Text] [Related]
9. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
Taniyama T; Azuma I; Yamamura Y
Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
12. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
[TBL] [Abstract][Full Text] [Related]
13. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
[TBL] [Abstract][Full Text] [Related]
14. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
Kawahara M; Matsuo K; Honda M
Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
16. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
Lagrange PH
Trop Med Parasitol; 1990 Sep; 41(3):304-6. PubMed ID: 2255850
[No Abstract] [Full Text] [Related]
17. A long-lasting enhancing effect of anti-tuberculin antiserum on delayed-type hypersensitivity reaction in BCG-infected guinea pigs.
Mauch H; Hammer HJ; Kümel G
Immunobiology; 1980 Jan; 156(4-5):477-82. PubMed ID: 6989751
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice.
Kawamura I; Tsukada H; Yoshikawa H; Fujita M; Nomoto K; Mitsuyama M
J Immunol; 1992 May; 148(9):2887-93. PubMed ID: 1374103
[TBL] [Abstract][Full Text] [Related]
19. Delayed-type hypersensitivity and acquired resistance to plague in mice immunized with killed Yersinia pestis and immunoregulators.
Hurtrel B; Alonso JM; Lagrange PH; Hurtrel M
Immunology; 1981 Oct; 44(2):297-304. PubMed ID: 7028602
[TBL] [Abstract][Full Text] [Related]
20. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
Nakamura RM
Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
